GMOs to be used in chemotherapy

Sunday, 23 September, 2001

Thirty men with prostate cancer are to be turned into genetically modified organisms (GMOs) during trials at Birmingham's Queen Elizabeth Hospital, England, in an attempt to cure the disease by making cancerous cells a target for chemotherapy.

The therapy involves a genetically modified common-cold virus carrying the gene for nitroreductase injected directly into the prostate gland. Scientists believe that the virus will produce a protein in the cancerous cells that will make them a target for chemotherapy so that no healthy cells are damaged while the cancer is killed. The prostate is removed two days later to calculate the optimum dosage levels.

In another phase of the experiment, men with recurring prostate cancer will be injected with a modified virus before being given a 'pro-drug' which is only active in the presence of the protein trigger, nitroreductase.

Related News

AXT to distribute NT-MDT atomic force microscopes

Scientific equipment supplier AXT has announced a partnership with atomic force microscope (AFM)...

Epigenetic patterns differentiate triple-negative breast cancers

Australian researchers have identified a new method that could help tell the difference between...

Combined effect of pollutants studied in the Arctic

Researchers from the Fram Centre in Norway are conducting studies in Arctic waters to determine...

  • All content Copyright © 2020 Westwick-Farrow Pty Ltd